Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 163 Records) |
| Query Trace: Recurrence and BRCA1[original query] |
|---|
| Comparison between talazoparib and conventional chemotherapy in the treatment of HER2-positive breast cancer patients: A retrospective study. Frontiers in immunology 2022 13 901636. Wang Ning, Yu Xiaope |
| Platinum Resistance After PARPi Resistance in a gBRCAmt Recurrent Ovarian Cancer Patient: a Case Report. Reproductive sciences (Thousand Oaks, Calif.) 2022 Aug . Zhao Qian, Ni Jing, Dong Jiayin, Cheng Xianzhong, Xiao Li, Xue Qi, Xu Xia, Guo Wenwen, Chen Xiaoxia |
| Influence of germline BRCA genotype on the survival of patients with triple-negative breast cancer. Cancer research communications 2022 7 1 (3): 140-147. Villarreal-Garza Cynthia, Ferrigno Ana S, Aranda-Gutierrez Alejandro, Frankel Paul H, Ruel Nora H, Fonseca Alan, Narod Steven, Chavarri-Guerra Yanin, Sifuentes Erika, Magallanes-Hoyos Maria Cristina, Herzog Josef, Castillo Danielle, Alvarez-Gomez Rosa M, Mohar-Betancourt Alejandro, Weitzel Jeffrey |
| Inherited Germline Cancer Susceptibility Gene Variants in Individuals with Non-Muscle-Invasive Bladder Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2022 Jul . Pietzak Eugene J, Whiting Karissa, Srinivasan Preethi, Bandlamudi Chaitanya, Khurram Aliya, Joseph Vijai, Walasek Aleksandra, Bochner Emily, Clinton Timothy, Almassi Nima, Truong Hong, de Jesus Escano Manuel R, Wiseman Michal, Mandelker Diana, Kemel Yelena, Zhang Liying, Walsh Michael F, Cadoo Karen A, Coleman Jonathan A, Al-Ahmadie Hikmat, Rosenberg Jonathan E, Iyer Gopakumar V, Solit David B, Ostrovnaya Irina, Offit Kenneth, Robson Mark E, Stadler Zsofia K, Berger Michael F, Bajorin Dean F, Carlo Maria, Bochner Bernard |
| Impact of low versus negative estrogen/progesterone receptor status on clinico-pathologic characteristics and survival outcomes in HER2-negative breast cancer. NPJ breast cancer 2022 7 8 (1): 80. Yoder Rachel, Kimler Bruce F, Staley Joshua M, Schwensen Kelsey, Wang Yen Y, Finke Karissa, O'Dea Anne, Nye Lauren, Elia Manana, Crane Gregory, McKittrick Richard, Pluenneke Robert, Madhusudhana Sheshadri, Beck Larry, Shrestha Anuj, Corum Larry, Marsico Mark, Stecklein Shane R, Godwin Andrew K, Khan Qamar J, Sharma Priyan |
| Breast Cancer with Low Recurrence Score on Oncotype DX: Interplay Between Early Recurrence, Lobular Histology and BRCA Mutation. Oncology and therapy 2022 Jun . Zarbiv Yonaton, Wygoda Yael Berner, Grinshpun Albert, Hamburger Tamar, Sella Tamar, Breuer Shani, Maimon Ofra, Rottenberg Yakir, Peretz Tamar, Kadouri Lu |
| Prevalence of Pathogenic Germline BRCA1/2 Variants and Their Association with Clinical Characteristics in Patients with Epithelial Ovarian Cancer in a Rural Area of Japan. Genes 2022 6 13 (6): . Abe Akiko, Imoto Issei, Tange Shoichiro, Nishimura Masato, Iwasa Takes |
| Case report: Response to platinum agents and poly (adenosine diphosphate-ribose) polymerase inhibitor in a patient with BRCA1 c.5096G>A (R1699Q) intermediate-risk variant. Cancer treatment and research communications 2022 6 32 100587. Saito Ayumi, Tanioka Maki, Hirata Makoto, Watanabe Tomoko, Odaka Yoko, Shimoi Tatsunori, Sudo Kazuki, Noguchi Emi, Ishikawa Mitsuya, Yonemori K |
| Further refining 2020 ESGO/ESTRO/ESP molecular risk classes in patients with early-stage endometrial cancer: A propensity score-matched analysis. Cancer 2022 May . Nero Camilla, Pasciuto Tina, Cappuccio Serena, Corrado Giacomo, Pelligra Silvia, Zannoni Gian Franco, Santoro Angela, Piermattei Alessia, Minucci Angelo, Lorusso Domenica, Fanfani Francesco, Scambia Giovan |
| Effect of HIPEC according to HRD/BRCAwt genomic profile in stage III ovarian cancer: Results from the phase III OVHIPEC trial. International journal of cancer 2022 May . Koole Simone N, Schouten Philip C, Hauke Jan, Kluin Roel J C, Nederlof Petra, Richters Lisa K, Krebsbach Gabriele, Sikorska Karolina, Alkemade Maartje, Opdam Mark, Schagen van Leeuwen Jules H, Schreuder Henk W R, Hermans Ralph H M, de Hingh Ignace H J T, Mom Constantijne H, Arts Henriette J G, van Ham Maaike, van Dam Peter, Vuylsteke Peter, Sanders Joyce, Horlings Hugo M, van de Vijver Koen K, Hahnen Eric, van Driel Willemien J, Schmutzler Rita, Sonke Gabe S, Linn Sabine |
| Germline mutations in penetrant cancer predisposition genes are rare in men with prostate cancer selecting active surveillance. Cancer medicine 2022 4 11 (22): 4332-4340. Brady Lauren, Newcomb Lisa F, Zhu Kehao, Zheng Yingye, Boyer Hilary, Sarkar Navonil De, McKenney Jesse K, Brooks James D, Carroll Peter R, Dash Atreya, Ellis William J, Filson Christopher P, Gleave Martin E, Liss Michael A, Martin Frances, Morgan Todd M, Thompson Ian M, Wagner Andrew A, Pritchard Colin C, Lin Daniel W, Nelson Peter |
| BRCA1 Mutation: An Insidious Enemy with Multiple Facets…. Case reports in oncology 2022 4 15 (1): 238-244. Godin Pierrick, Duhoux Francois P, Mazzeo Filomena, Rojas Michel, Bollue Emmanuel, François Aline, Galant Christine, Coulie Julien, Coyette Maude, Lentini Audrey, Deswisen Yannick, Perlepe Vasiliki, Fellah Latifa, Leconte Isabelle, Berlière Marti |
| Clinicopathological features, genetic alterations, and BRCA1 promoter methylation in Japanese male patients with breast cancer. Breast cancer research and treatment 2022 12 197 (3): 593-602. Shimomura Akihiko, Yoshida Masayuki, Kubo Takashi, Yamashita Satoshi, Noguchi Emi, Nagayama Aiko, Hanamura Toru, Okazaki Miki, Mukohara Toru, Tsuruga Asako, Tanaka Kiyo, Kawamura Yukino, Higuchi Toru, Takahashi Yoko, Kurozumi Sasagu, Hayashida Tetsu, Ichikawa Hitoshi, Ushijima Toshikazu, Suto Akihi |
| Analysis of matched primary and recurrent BRCA1/2 mutation-associated tumors identifies recurrence-specific drivers. Nature communications 2022 11 13 (1): 6728. Shah Jennifer B, Pueschl Dana, Wubbenhorst Bradley, Fan Mengyao, Pluta John, D'Andrea Kurt, Hubert Anna P, Shilan Jake S, Zhou Wenting, Kraya Adam A, Llop Guevara Alba, Ruan Catherine, Serra Violeta, Balmaña Judith, Feldman Michael, Morin Pat J, Nayak Anupma, Maxwell Kara N, Domchek Susan M, Nathanson Katherine |
| Comparison of Clinical, Pathological, and Prognostic Features in BRCA Mutant and Wild-Type Male Breast Cancer Patients. European journal of breast health 2022 10 18 (4): 323-328. Do?an ?zzet, Ayd?n Esra, Yaz?c? Hülya, Saip P?n |
| BRCA Mutation Status in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Pivotal Role for Treatment Decision-Making. Cancers 2022 Sep 14 (19): . Pavese Francesco, Capoluongo Ettore Domenico, Muratore Margherita, Minucci Angelo, Santonocito Concetta, Fuso Paola, Concolino Paola, Di Stasio Enrico, Carbognin Luisa, Tiberi Giordana, Garganese Giorgia, Corrado Giacomo, Di Leone Alba, Generali Daniele, Fragomeni Simona Maria, D'Angelo Tatiana, Franceschini Gianluca, Masetti Riccardo, Fabi Alessandra, Mulè Antonino, Santoro Angela, Belli Paolo, Tortora Giampaolo, Scambia Giovanni, Paris I |
| Three cases of colon cancer in four generations of the Saudi family, caused by endogamous germline mutations. Cellular and molecular biology (Noisy-le-Grand, France) 2023 9 69 (8): 163-171. Dalal S Alshaya, Tahani Mohamed Ibrahim Al-Hazani, Mashael Alhumaidi Alotaibi, Dalia Mostafa Domiaty, Eman Alshehri, Maha Abdulla Alwaili, Amani Mohammed Alotaibi, Areej Saud Jalal, Alaa Ali AlQahtani, Fatima Abdullah AlQassim, Gadah Albasher, Wedad Saeed Al-Qahta |
| Survival Outcomes and Efficacy of Platinum in Early Breast Cancer Patients with Germline BRCA1 or BRCA2 Mutation: A Multicenter Retrospective Cohort Study. Breast cancer (Dove Medical Press) 2023 9 15 671-682. Xi Chen, Xiaoyan Qian, Min Xiao, Pin Zha |
| Integrated Multimodal Analyses of DNA Damage Response and Immune Markers as Predictors of Response in Metastatic Triple-Negative Breast Cancer in the TNT Trial (NCT00532727). Clinical cancer research : an official journal of the American Association for Cancer Research 2023 8 OF1-OF15. Holly Tovey, Orsolya Sipos, Joel S Parker, Katherine A Hoadley, Jelmar Quist, Sarah Kernaghan, Lucy Kilburn, Roberto Salgado, Sherene Loi, Richard D Kennedy, Ioannis Roxanis, Patrycja Gazinska, Sarah E Pinder, Judith Bliss, Charles M Perou, Syed Haider, Anita Grigoriadis, Andrew Tutt, Maggie Chon U Chea |
| A comprehensive analysis of Fanconi anemia genes in Chinese patients with high-risk hereditary breast cancer. Journal of cancer research and clinical oncology 2023 8 . Qiao-Yan Zhu, Pu-Chun Li, Yi-Fan Zhu, Jia-Ni Pan, Rong Wang, Xiao-Lin Li, Wei-Wu Ye, Xiao-Wen Ding, Xiao-Jia Wang, Wen-Ming C |
| Genomic analyses of germline and somatic variation in high-grade serous ovarian cancer. Journal of ovarian research 2023 7 16 (1): 141. A W Adamson, Y C Ding, L Steele, L A Leong, R Morgan, M T Wakabayashi, E S Han, T H Dellinger, P S Lin, A A Hakim, S Wilczynski, C D Warden, S Tao, V Bedell, M C Cristea, S L Neuhaus |
| Comparison of PARPi efficacy according to homologous recombination deficiency biomarkers in patients with ovarian cancer: a systematic review and meta-analysis. Chinese clinical oncology 2023 5 . Felipe Batalini, Laercio Lopes DaSilva, Leticia Campoverde, Ana Carolina Marin Comini, Bruno Murad Carvalho, Wilson Nogueira, Hyan Silveira, Brenda J Ernst, Lida A Mi |
| Genomic Analyses of Germline and Somatic Variation in High-Grade Serous Ovarian Cancer. Research square 2023 3 . Adamson Aaron W, Ding Yuan Chun, Steele Linda, Leong Lucile A, Morgan Robert, Wakabayashi Mark T, Han Ernest S, Dellinger Thanh H, Lin Paul S, Hakim Amy A, Wilczynski Sharon, Warden Charles D, Tao Shu, Bedell Victoria, Cristea Mihaela C, Neuhausen Susan |
| Impact of multifocal or multicentric disease on local recurrence and survival in breast cancer patients with or without BRCA1/2 variants. Breast cancer research and treatment 2023 3 . Liu Xuejing, Wang Yanjie, Cao Kun, Yao Lu, Hu Li, Sun Jie, Zhang Juan, Xu Ye, Xie Yunt |
| Survival outcomes in patients with BRCA mutated, variant of unknown significance, and wild type ovarian cancer treated with PARP inhibitors. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2023 2 . Musacchio Lucia, Boccia Serena, Marchetti Claudia, Minucci Angelo, Camarda Floriana, Cassani Chiara, Ventriglia Jole, Salutari Vanda, Ghizzoni Viola, Giudice Elena, Perri Maria Teresa, Carbone Maria Vittoria, Ricci Caterina, Pignata Sandro, Fagotti Anna, Scambia Giovanni, Lorusso Domeni |
| Is Breast Conserving Surgery Efficacious in Breast Cancer Patients with BRCA1 or BRCA2 Germline Mutation? Breast cancer (Dove Medical Press) 2023 2 15 163-173. Emiroglu Selman, Özkurt Enver, Cab?oglu Neslihan, Igci Abdullah, Saip Pinar, Yazici Hulya, Ozmen Tolga, Ozmen Vahit, Muslumanoglu Mahmut, Tukenmez Musta |
| Efficacy of poly (ADP-ribose) polymerase inhibitors monotherapy and the impact to subsequent platinum-based chemotherapy in breast cancer susceptibility genes1/2-mutated ovarian cancer patients with secondary platinum-sensitive relapse. Journal of ovarian research 2023 10 16 (1): 209. Yana Ma, Jiale Liu, Ning Li, Hualei Bu, Yongwen Huang, Chengjuan Jin, Hao Wen, Shuai Feng, Hui Zhang, Xiaorong Yang, Beihua Kong, Lingying Wu, Kun So |
| Whole exome germline sequencing in early-onset prostate cancer patients: Genomic findings and clinical outcomes. The Prostate 2023 10 . Nava Siegelmann-Danieli, Victoria Neiman, Avital Bareket-Samish, Racheli Berger, Asaf Peretz, Hillel Alapi, Erez Tsur, Tal Patalon, Daniella Beller, Galit Rimler, Gabriel Chodick, Mordechai Shoh |
| Survival Outcomes in Women with Unilateral, Triple-Negative, Breast Cancer Correlated with Contralateral Prophylactic Mastectomy. Annals of surgical oncology 2023 1 . Fasano Genevieve A, Bayard Solange, Chen Yalei, Marti Jennifer, Simmons Rache, Swistel Alexander, Bensenhaver Jessica, Davis Melissa, Newman Li |
| Estimating copy number to determine BRCA2 deletion status and to expect prognosis in localized prostate cancer. Cancer medicine 2023 1 . Nukaya Takuhisa, Sumitomo Makoto, Sugihara Eiji, Takeda Mayu, Nohara Sachio, Tanishima Shigeki, Takenaka Masashi, Zennami Kenji, Takahara Kiyoshi, Shiroki Ryoichi, Saya Hideyu |
- Page last reviewed:Oct 1, 2023
- Page last updated:Nov 28, 2023
- Content source: